Live Breaking News & Updates on Huiping Li

Stay updated with breaking news from Huiping li. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fuzuloparib Alone or With Apatinib Bests Chemo in BRCA-Mutated Breast Cancer

Fuzuloparib, with or without apatinib, improved PFS over chemotherapy in patients with previously treated, HER2-negative, BRCA-mutated breast cancer. ....

United States , Huiping Li , University Cancer Hospital , Peking University Cancer Hospital ,

Fuzuloparib Alone or With Apatinib Bests Chemo in BRCA-Mutated Breast Cancer

Fuzuloparib Alone or With Apatinib Bests Chemo in BRCA-Mutated Breast Cancer
cancertherapyadvisor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cancertherapyadvisor.com Daily Mail and Mail on Sunday newspapers.

United States , Huiping Li , University Cancer Hospital , Peking University Cancer Hospital ,

Fuzuloparib ± Apatinib Significantly Boosts PFS in BRCA+ HER2– Metastatic Breast Cancer

Fuzuloparib ± Apatinib Significantly Boosts PFS in BRCA+ HER2– Metastatic Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Huiping Li , Translational Research , Key Laboratory Of Carcinogenesis , Key Laboratory , Breast Oncology , Peking University Cancer Hospital ,

Sacibertinib Plus Endocrine Therapy Shows Early Safety, Activity in ER+/HER2+ Breast Cancer

Sacibertinib plus endocrine therapy demonstrated acceptable safety with early clinical activity in patients with estrogen receptor-positive/HER2-positive metastatic breast cancer. ....

San Antonio , United States , Huiping Li , University Cancer Hospital , Antonio Breast Cancer , Peking University Cancer Hospital , Neoadjuvant Her2 , Breast Cancer , Onclive Tv , The 2023 San Antonio Breast Cancer Symposium ,